| Date Filed | Type | Description |
| 07/25/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/18/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/27/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/27/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/25/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/01/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/18/2022 |
SC 13G
| Assenagon Asset Management S.A. reports a 0% stake in CATALYST BIOSCIENCES INC |
| 11/24/2021 |
SC 13G
| Assenagon Asset Management S.A. reports a 3.2% stake in MINERVA NEUROSCIENCES INC |
| 11/24/2021 |
SC 13G
| Assenagon Asset Management S.A. reports a 14.2% stake in MINERVA NEUROSCIENCES INC |
| 10/19/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 07/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/26/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/01/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/07/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/04/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/04/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/21/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/24/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/24/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/19/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 107% stake in CATALYST BIOSCIENCES, INC. |
| 06/19/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 6.4% stake in CATALYST BIOSCIENCES, INC. |
| 06/17/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 102% stake in AFFIMED N.V. |
| 06/16/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 102% stake in AFFIMED N.V. |
| 06/16/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 6.5% stake in AFFIMED N.V. |
| 04/17/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 3% stake in MagnaChip Semiconductor Corporation |
| 04/17/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 04/17/2020 |
SC 13G
| Assenagon Asset Management S.A. reports a 6.9% stake in MagnaChip Semiconductor Corporation |
| 01/17/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 10/16/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/08/2019 |
SC 13G/A
| Assenagon Asset Management S.A. reports a 3% stake in IMPINJ INC |
|